NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PharmaGap Inc. 

100 Sussex Drive

Ottawa  Ontario  K1A-0R6  Canada
Phone: 613-998-3400 Fax: 613-998-3399


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Proteomics





 Company News
PharmaGap Inc. (GAP) Reports That GAP-107B8 Showed Strong and Consistent Anti-Cancer Activity in a Wide Range of Cancers in NCI Test 10/27/2009 1:08:01 PM    More...
PharmaGap Inc. (GAP) Announces Completion of Securities Lending Arrangements with Stormont 10/21/2009 2:14:09 PM    More...
PharmaGap Inc. (GAP) Advises That National Cancer Institute Test Results Are Completed and Expected To Be Provided To The Company Shortly 10/20/2009 2:18:14 PM    More...
Results from National Cancer Institute Five-Dose Study of PharmaGap Inc. (GAP) Cancer Drug Expected Late September 9/2/2009 2:58:41 PM    More...
PharmaGap Inc. (GAP) Advised By U.S. National Cancer Institute Of Positive Results Of Testing for the Company's Lead Cancer Drug GAP-107B8 8/13/2009 2:02:15 PM    More...
PharmaGap Inc. (GAP) Releases Results of Initial Testing For Novel Cancer Drug Compound at the Ottawa Hospital Research Institute 8/6/2009 11:54:43 AM    More...
PharmaGap Inc. (GAP) Provides Guidance on Cancer Drug Testing Timetable 7/17/2009 9:28:52 AM    More...
PharmaGap Inc. (GAP) Raises Additional Equity Financing 7/16/2009 12:33:51 PM    More...
PharmaGap Inc. (GAP) Announces Agreement for the Issuance of Shares to National Research Council of Canada 6/23/2009 1:56:07 PM    More...
PharmaGap Inc. (GAP) Announces Completion of $861,920 Private Placement 6/17/2009 11:32:45 AM    More...
1234